As many research fields of hepatitis propose the therapeutic potential of HO-1 against inflammatory flare in liver damage, our study results may help to allocate patients to a specific risk profile, including the (GT)n genotype before treatment with HO-1 is considered. The gene discussed is HMOX1; the disease is hepatitis A virus infection.